Benjamin F. Edwards & Company’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-150
Closed -$1K 2001
2019
Q1
$1K Hold
150
﹤0.01% 1684
2018
Q4
$2K Sell
150
-100
-40% -$1.69K ﹤0.01% 1624
2018
Q3
$5K Hold
250
﹤0.01% 1427
2018
Q2
$6K Hold
250
﹤0.01% 1398
2018
Q1
$5K Hold
250
﹤0.01% 1426
2017
Q4
$5K Hold
250
﹤0.01% 1381
2017
Q3
$5K Hold
250
﹤0.01% 1331
2017
Q2
$4K Hold
250
﹤0.01% 1297
2017
Q1
$4K Buy
+250
New +$3.61K ﹤0.01% 1212
2016
Q4
Sell
-2,050
Closed -$57K 1282
2016
Q3
$57K Sell
2,050
-310
-13% -$10.4K 0.01% 519
2016
Q2
$83K Sell
2,360
-909
-28% -$28.6K 0.02% 440
2016
Q1
$90K Hold
3,269
0.02% 413
2015
Q4
$112K Buy
3,269
+1,982
+154% +$61.8K 0.02% 389
2015
Q3
$37K Buy
1,287
+687
+115% +$29.4K 0.01% 589
2015
Q2
$27K Buy
+600
New +$22.6K 0.01% 720

Other funds holding DPLO

Benjamin F. Edwards & Company's DPLO Position: Q2 2019 in Review

Benjamin F. Edwards & Company sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2019, closing a stake of 150 shares — an estimated $1K sold.

Benjamin F. Edwards & Company first reported a position in DPLO in Q2 2015 and held it in 15 quarters. The position peaked at $112K in Q4 2015. 131 funds tracked by Wall St. Rank hold DPLO as of Q2 2019.

  • Benjamin F. Edwards & Company reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2019 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 150 DIPLOMAT PHARMACY, INC. shares in Q2 2019, an estimated $1K.
  • Benjamin F. Edwards & Company first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2015 and held it in 15 quarters.
  • Benjamin F. Edwards & Company's DIPLOMAT PHARMACY, INC. position peaked at $112K in Q4 2015.
  • 131 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2019.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2019, filed 8 Aug 2019.